Citius Pharmaceuticals is trading at $0.60 (up 7.6%) in after-hours trading after closing at $0.56 on July 9, 2026, despite a lack of new company-specific developments.
- Current filings and news show no fresh earnings reports, FDA decisions, or major analyst calls released late Thursday.
- The move appears to be a modest, low-volume after-hours bounce occurring alongside broader gains in major market indices.